| NCT04705987 | Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia | HEART FAILURE | 2021-02-08 | PHASE3 |
| NCT05017571 | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | Obesity|Insulin Resistance|Inflammation | 2021-11-08 | PHASE2 |
| NCT05936281 | Changchun GeneScience Pharmaceutical Co., Ltd.|Huashan Hospital | Gout|Gout Initiating Urate-loweringUrate-lowering Therapy | 2023-07-20 | PHASE2 |
| NCT02939573 | University of Pennsylvania|National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)|National Center for Advancing Translational Sciences (NCATS)|Office of Rare Diseases (ORD) | Primary Cutaneous Vasculitis|Cutaneous Polyarteritis Nodosa|IgA Vasculitis|Henoch-Sch?nlein Purpura | 2017-01-01 | PHASE2 |
| NCT04724629 | University of Sao Paulo|Conselho Nacional de Desenvolvimento Científico e Tecnológico|Science Valley Research Institute | Covid19 | 2021-01-05 | PHASE3 |
| NCT01017003 | Mutual Pharmaceutical Company, Inc. | Pharmacokinetics | 2007-09 | PHASE1 |
| NCT06286423 | University of Virginia | Heart Failure|Decompensated Heart Failure|Heart Failure With Reduced Ejection Fraction | 2024-06 | PHASE4 |
| NCT05930002 | Ain Shams University | COVID-19 | 2021-07-21 | NA |
| NCT05439356 | Beijing Tiantan Hospital | Ischemic Stroke|TIA | 2022-08-11 | PHASE3 |
| NCT05476991 | Assistance Publique - H?pitaux de Paris | Stroke|Stroke, Ischemic|Atherosclerosis|Myocardial Infarction|Coronary Syndrome|TIA|Cardiac Disease|Cerebral Infarction | 2023-05-17 | PHASE3 |
| NCT01040845 | Mutual Pharmaceutical Company, Inc. | Pharmacokinetics | 2007-08 | PHASE1 |
| NCT05246072 | Ain Shams University | COVID-19 | 2021-11-01 | PHASE4 |
| NCT03128905 | Lille Catholic University|University Hospital, Lille|Hopital Lariboisière|Bichat Hospital|Valenciennes Hospital Centre|Armentières Hospital Centre|Dunkerque Hospital Centre | Chondrocalcinosis | 2018-02-05 | PHASE3 |
| NCT00984061 | Mutual Pharmaceutical Company, Inc. | Pharmacokinetics | 2007-11 | PHASE1 |
| NCT07145229 | Atom Therapeutics Co., Ltd | Acute Gouty Arthritis|Gout Flare|Gout Flares|Acute Gout Flare | 2025-08-26 | PHASE2 |
| NCT00983216 | Mutual Pharmaceutical Company, Inc. | Pharmacokinetics | 2008-07 | PHASE1 |
| NCT06215989 | Beijing Anzhen Hospital | Acute Coronary Syndrome|Unstable Angina|ST Elevation Myocardial Infarction|Non ST Segment Elevation Myocardial Infarction|Colchicine | 2024-09-02 | NA |
| NCT03015831 | Jordan Collaborating Cardiology Group | Atrial Fibrillation|Cardiac Surgery|Colchicine Adverse Reaction | 2017-10-02 | PHASE3 |
| NCT05361772 | Guangdong Provincial People´s Hospital|The First Affiliated Hospital of Guangzhou Medical University|Shenzhen People´s Hospital|Peking University Shougang Hospital|Peking Union Medical College Hospital|Second Xiangya Hospital of Central South University|Zhongshan People´s Hospital, Guangdong, China|Shenzhen Baoan District People´s Hospital | Colchicine|Abdominal Aortic Aneurysm|Progression | 2022-06-01 | NA |
| NCT02128490 | Takeda | Gout|Moderate Renal Impairment | 2014-05 | PHASE2 |
| NCT06936709 | Geisinger Clinic|St. Luke´s Hospital, Kansas City, Missouri | Osteoarthritis of Knee|Recovery Following Primary Total Knee Arthroplasty|Perioperative Pain Control | 2025-12-01 | PHASE4 |
| NCT07411768 | China National Center for Cardiovascular Diseases|Chinese Academy of Medical Sciences | Transcatheter Aortic Valve Replacement|Transcatheter Heart Valve Thrombosis|Anti-inflammatory Therapy | 2026-03 | NA |
| NCT00819585 | Novartis Pharmaceuticals | Gout | 2008-12 | PHASE2 |
| NCT05130892 | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | NLRP3|hsCRP|Percutaneous Coronary Intervention | 2021-11-15 | PHASE4 |
| NCT04870424 | Insel Gruppe AG, University Hospital Bern | Transcatheter Aortic Valve Replacement|Atrial Fibrillation New Onset|Pacemaker|Colchicine | 2021-09-21 | PHASE3 |
| NCT04667780 | Ayub Teaching Hospital|Universidad de Murcia | COVID-19 | 2020-12-01 | PHASE3 |
| NCT03693781 | Azienda Ospedaliero-Universitaria di Modena|University of Modena and Reggio Emilia|University of Turin, Italy|Istituto Auxologico Italiano|IRCCS National Neurological Institute "C. Mondino" Foundation|University of Bari|IRCCS San Raffaele|University of Padova|University of Milan|Istituto Di Ricerche Farmacologiche Mario Negri|University of Campania Luigi Vanvitelli|Catholic University of the Sacred Heart | Amyotrophic Lateral Sclerosis | 2019-04-10 | PHASE2 |
| NCT04181996 | Ottawa Heart Institute Research Corporation|Canadian Institutes of Health Research (CIHR) | Cardiovascular Diseases|Atherosclerosis|Inflammation|Diabetes | 2020-08-01 | PHASE3 |
| NCT04601883 | Henning Bliddal | Osteoarthritis Hand|Osteoarthritis Finger | 2021-01-15 | PHASE4 |
| NCT00960323 | Mutual Pharmaceutical Company, Inc. | Healthy | 2009-02 | PHASE1 |
| NCT06270225 | Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. | Gout Arthritis | 2024-03-30 | PHASE2 |
| NCT04155879 | Hillel Yaffe Medical Center | Atrial Fibrillation | 2019-11 | NA |
| NCT04392141 | Kermanshah University of Medical Sciences | COVID-19 | 2020-04-01 | PHASE1|PHASE2 |
| NCT00370760 | Shahid Beheshti University of Medical Sciences | Proliferative Vitreoretinopathy | 2006-09 | PHASE3 |
| NCT03310125 | Population Health Research Institute|Hamilton Health Sciences Corporation | Atrial Fibrillation|Atrial Flutter|Myocardial Injury After Non-Cardiac Surgery | 2018-02-14 | PHASE3 |
| NCT06543082 | CHA University|Biotronik SE & Co. KG | Acute Coronary Syndrome | 2024-08-05 | PHASE4 |
| NCT06998862 | Hospital General Universitario Gregorio Mara?on | Chronic Kidney Disease|Cardiovascular Events | 2025-02-12 | PHASE3 |
| NCT01935700 | Kaohsiung Medical University Chung-Ho Memorial Hospital | Hepatocellular Carcinoma|Metastasis|Invasion | 2013-06-06 | PHASE2 |
| NCT01451645 | Regeneron Pharmaceuticals | Intercritical Gout | 2011-10 | PHASE4 |
| NCT02602028 | Saglik Bilimleri Universitesi Gulhane Tip Fakultesi | Familial Mediterranean Fever | 2011-04 | PHASE4 |
| NCT06146192 | Istanbul University - Cerrahpasa | Beh?et´s Syndrome | 2023-11-20 | |
| NCT00983177 | Bnai Zion Medical Center | Calcific Tendonitis | 2010-03 | NA |
| NCT04416334 | Instituto de Investigación Marqués de Valdecilla|Gerencia de atención primaria área 1|Gerencia de atención primaria área 2|Gerencia Atencion Primaria Area 3|Gerencia de atención primaria área 4 | SARS-CoV-2 Infection (COVID-19) | 2020-08-19 | PHASE3 |
| NCT05928728 | Herlev and Gentofte Hospital | Atrial Fibrillation | 2023-07-03 | PHASE3 |
| NCT06847204 | Zaeema Kanwal | COVID - 19 | 2025-02-24 | PHASE1|PHASE2 |
| NCT03735134 | Hillel Yaffe Medical Center | Inflammation|Myocardial Infarction | 2018-11 | NA |
| NCT05850091 | Massachusetts General Hospital|National Heart, Lung, and Blood Institute (NHLBI) | Coronary Artery Disease | 2023-12-07 | PHASE4 |
| NCT06396858 | Brazilian Clinical Research Institute|Allian?a Diagnostic | Ischemic Stroke | 2026-07 | PHASE4 |
| NCT03048825 | Population Health Research Institute|Boston Scientific Corporation|Canadian Institutes of Health Research (CIHR) | ST Elevation Myocardial Infarction|Non ST Elevation Myocardial Infarction | 2018-02-01 | PHASE3 |
| NCT02063997 | Gilead Sciences | Gout | 2014-03 | PHASE2 |
| NCT02898610 | University College Dublin|Health Research Board, Ireland|Irish Heart Foundation|University of Limerick|University of Edinburgh|National University of Ireland, Galway, Ireland|Universitat de Lleida|Universitaire Ziekenhuizen KU Leuven | Ischemic Attack, Transient|Stroke | 2016-12-12 | PHASE3 |
| NCT06304896 | Arab Contractors Medical Centre | Chemotherapy Induced Systolic Dysfunction | 2024-05-01 | PHASE1 |
| NCT06217120 | Montreal Heart Institute | Heart Failure With Preserved Ejection Fraction|Microvascular Coronary Artery Disease | 2024-03-01 | PHASE2|PHASE3 |
| NCT01001052 | Mutual Pharmaceutical Company, Inc. | Healthy | 2009-10 | PHASE1 |
| NCT02594111 | VA Office of Research and Development|NYU Langone Health | Coronary Artery Disease|Acute Coronary Syndrome | 2013-05-30 | PHASE4 |
| NCT05175274 | Qingdao Central Hospital|Qingdao Municipal Hospital | Coronary Artery Disease | 2022-12-06 | PHASE3 |
| NCT06203977 | Hamilton Health Sciences Corporation|Hamilton Academic Health Sciences Organization|St. Joseph´s Health Care London | Chronic Kidney Diseases|Renal Failure | 2024-11-15 | PHASE1 |
| NCT05118737 | Hamad Medical Corporation | COVID-19 Pneumonia | 2021-10-01 | EARLY_PHASE1 |
| NCT06768294 | I.R.C.C.S Ospedale Galeazzi-Sant´Ambrogio | Calcium Pyrophosphate Deposition Disease|Chondrocalcinosis | 2025-01 | PHASE2 |
| NCT00370201 | Shahid Beheshti University of Medical Sciences | Rhegmatogenous Retinal Detachment | 2004-03 | PHASE3 |
| NCT02176460 | Singapore General Hospital|Duke University|Duke-NUS Graduate Medical School | Knee Osteoarthritis | 2013-10 | PHASE2|PHASE3 |
| NCT07569328 | Beijing Anzhen Hospital | CAD - Coronary Artery Disease|CABG|Colchicine | 2026-09-01 | NA |
| NCT04224545 | Bakulev Scientific Center of Cardiovascular Surgery | Colchicine Adverse Reaction|Atrial Fibrillation New Onset | 2019-12-23 | PHASE4 |
| NCT07232069 | Duke University|National Heart, Lung, and Blood Institute (NHLBI)|University of North Carolina, Chapel Hill|Massachusetts General Hospital|Johns Hopkins University | Coronary Artery Disease Risk Factors Multiple|Coronary Artery Disease Progression|Prevention & Control|Premature Atherosclerosis | 2026-07-01 | PHASE3 |
| NCT07129538 | Cairo University | Familial Mediterranean Fever | 2025-05-10 | NA |
| NCT04360980 | Shahid Beheshti University of Medical Sciences | COVID-19 | 2020-03-20 | PHASE2 |
| NCT07035405 | Beijing Tiantan Hospital|Shenzhen Medical Academy of Research and Translation | Stroke | 2025-07-04 | PHASE3 |
| NCT07536373 | Shin Kong Wu Ho-Su Memorial Hospital|National Taiwan University Hospital|Chi Mei Medical Hospital|Taipei Veterans General Hospital, Taiwan|Chang Gung Memorial Hospital | Chronic Limb-Threatening Ischemia | 2026-04-15 | PHASE3 |
| NCT03704181 | University of Sao Paulo General Hospital|Funda??o de Amparo à Pesquisa do Estado de S?o Paulo | Chagas Disease|Colchicine Resistance | 2018-10-01 | PHASE2 |
| NCT06469528 | King´s College Hospital NHS Trust|King´s College London | Coronary Artery Disease | 2024-06-24 | PHASE3 |
| NCT04857931 | Montreal Heart Institute | Heart Failure|Inflammation|Colchicine | 2022-06-17 | PHASE2 |
| NCT00983372 | Mutual Pharmaceutical Company, Inc. | Healthy; Adult; Volunteer; Colchicine; Pharmacokinetics; Diltiazem; Cytochrome p450 3A4; P-glycoprotein | 2008-08 | PHASE1 |
| NCT05200052 | Ain Shams University | Anterior MI|Colchicine | 2022-02-01 | PHASE4 |
| NCT04756128 | HealthPartners Institute|Park Nicollet Foundation | Covid19 | 2021-01-25 | PHASE2 |
| NCT00004368 | National Center for Research Resources (NCRR)|Children´s Hospital Colorado | Cirrhosis|Liver Cirrhosis | 1990-05 | PHASE1 |
| NCT06802926 | Ruijin Hospital | CABG|Graft Failure|Colchicine | 2025-12-29 | PHASE4 |
| NCT04403243 | Lomonosov Moscow State University Medical Research and Educational Center | COVID 19 | 2020-05-08 | PHASE2 |
| NCT04073797 | University of Cambridge|Cambridge University Hospitals NHS Foundation Trust|Wellcome Trust|GE Healthcare|Lund University | Hypercholesterolemia|Hypercholesterolemia, Familial|Atherosclerosis|Carotid Artery Plaque | 2023-03-20 | NA |
| NCT06567678 | The University of The West Indies | Coronary Artery Disease | 2024-08-21 | PHASE1 |
| NCT01906749 | Maria Vittoria Hospital | Acute Coronary Syndrome | 2013-06 | PHASE4 |
| NCT03131583 | Jiangsu HengRui Medicine Co., Ltd. | Gout | 2017-02-17 | PHASE1 |
| NCT06426537 | University of Brawijaya | ST-Elevation Myocardial Infarction | 2022-10-20 | EARLY_PHASE1 |
| NCT07432529 | Azienda Sanitaria Locale ASL 6, Livorno | Venous Thrombosis Deep (Limbs)|Post-thrombotic Syndrome|Venous Thromboembolism (VTE)|Venous Insufficiency | 2026-06-01 | PHASE3 |
| NCT02153983 | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|National Heart, Lung, and Blood Institute (NHLBI) | Obesity|Metabolic Disease | 2014-05-31 | PHASE1|PHASE2 |
| NCT05911022 | Ain Shams University | COVID-19 | 2021-07-01 | NA |
| NCT00506883 | Takeda | Gout | 2007-04 | PHASE3 |
| NCT02260206 | Yong Seog Oh | Pericardial Effusion | 2014-07 | PHASE4 |
| NCT06118034 | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School|First Affiliated Hospital of Zhejiang University|Jinan Central Hospital|The First People´s Hospital of Changzhou|Xinhua hospital of ILi in Kazakhstan automomous district|First Affiliated Hospital of Harbin Medical University|Yangzhou University|Shandong Provincial Hospital|Huai´an First People´s Hospital|The First Affilated Hospital of the Medical College, Shihezi University|Affiliated Hospital of Nantong University | Inflammatory Response|Cardiac Disease | 2024-01-28 | PHASE3 |
| NCT01130051 | Mutual Pharmaceutical Company, Inc. | Healthy | 2010-05 | PHASE1 |
| NCT06078904 | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Coronary Artery Disease|Percutaneous Coronary Intervention | 2023-10-10 | PHASE4 |
| NCT01994226 | Keele University | Gout | 2014-01 | PHASE4 |
| NCT04867226 | Hawler Medical University | Coronavirus Infection | 2021-05-08 | PHASE2 |
| NCT06025071 | Chinese Academy of Medical Sciences, Fuwai Hospital | Percutaneous Coronary Intervention|Multivessel Coronary Artery Disease|Elderly Patients|C-Reactive Protein | 2023-09 | PHASE4 |
| NCT03376698 | University of the Ryukyus | Colchicine|Diabetes Mellitus, Type 2|Coronary Artery Disease|White Blood Cell|Inflammation|Diarrhea | 2017-06-15 | PHASE2 |
| NCT06062277 | University College Dublin|Mater Misericordiae University Hospital | Ischemic Stroke|Atherosclerosis | 2023-10 | PHASE2 |
| NCT00983905 | Mutual Pharmaceutical Company, Inc. | Pharmacokinetics | 2008-08 | PHASE1 |
| NCT05785429 | Donders Centre for Cognitive Neuroimaging|Radboud University Medical Center|HAN University of Applied Sciences | Overweight and Obesity | 2022-08-02 | NA |
| NCT05802992 | Affiliated Hospital of Nantong University | Multiple Myeloma | 2022-03-30 | PHASE3 |
| NCT04916522 | Herlev and Gentofte Hospital|University of Copenhagen | Hypertension | 2021-08-10 | PHASE2 |
| NCT02177266 | Mayo Clinic | Atrial Fibrillation|Post-pericardiotomy Syndrome|Constriction | 2015-05 | PHASE3 |
| NCT00128414 | Azienda Sanitaria Locale 3, Torino | Pericarditis|Recurrence | 2005-08 | PHASE3 |
| NCT02582190 | Elpen Pharmaceutical Co. Inc. | Atrial Fibrillation | 2017-12-02 | PHASE3 |
| NCT00983515 | Mutual Pharmaceutical Company, Inc. | Pharmacokinetics | 2008-07 | PHASE1 |
| NCT06081049 | Tor Biering-S?rensen | Heart Failure With Preserved Ejection Fraction | 2024-01-18 | PHASE2 |
| NCT04355143 | University of California, Los Angeles | COVID-19 | 2020-05-01 | PHASE2 |
| NCT03210610 | Sheba Medical Center | FMF|Colchicine Resistance|Colchicine Toxicity | 2017-10-19 | |
| NCT05936268 | Changchun GeneScience Pharmaceutical Co., Ltd.|Huashan Hospital | Acute Gout|Gout Flare | 2023-07-21 | PHASE2 |
| NCT04322682 | Montreal Heart Institute|National Heart, Lung, and Blood Institute (NHLBI)|Bill and Melinda Gates Foundation|The Government of Quebec|Dacima Software Inc. | Corona Virus Infection | 2020-03-23 | PHASE3 |
| NCT04774159 | Population Health Research Institute | Peripheral Arterial Disease|Atherosclerosis of Extremities|Inflammation | 2021-05-06 | PHASE3 |
| NCT04762771 | Baptist Health South Florida|University of California, Los Angeles | Covid19 | 2020-12-23 | PHASE1|PHASE2 |
| NCT07064109 | Shanghai Tongji Hospital, Tongji University School of Medicine | ACS - Acute Coronary Syndrome | 2025-07-01 | NA |
| NCT04350320 | Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia | COVID19 | 2020-04-30 | PHASE3 |
| NCT01936285 | G.Gennimatas General Hospital | Acute Myocardial Infarction | 2013-07 | PHASE4 |
| NCT04818489 | ClinAmygate | Covid19|Pulmonary Fibrosis Interstitial | 2021-03-25 | PHASE4 |
| NCT06765356 | Vivek Reddy|Boston Scientific Corporation | Persistent Atrial Fibrillation|Paroxysmal Atrial Fibrillation|Long-standing Persistent Atrial Fibrillation | 2025-04-15 | PHASE4 |
| NCT06095765 | AZ Sint-Jan AV|University Hospital, Ghent|Belgium Health Care Knowledge Centre | Coronary Artery Disease | 2024-01-29 | PHASE3 |
| NCT00754819 | Hamilton Health Sciences Corporation | Acute Coronary Syndrome | 2008-04 | PHASE2|PHASE3 |
| NCT01601132 | Takeda | Healthy | 2012-05 | PHASE4 |
| NCT00983242 | Mutual Pharmaceutical Company, Inc. | Pharmacokinetics | 2008-09 | PHASE1 |
| NCT05162742 | Radboud University Medical Center | Aortic Valve Disease|Aortic Valve Stenosis|Aortic Valve Calcification|Inflammation|Calcification|Cardiovascular Diseases | 2022-12-22 | PHASE3 |
| NCT07362966 | Shenyang Northern Hospital | Colchicine|Coronary Atherosclerosis Management|Clonal Hematopoiesis of Indeterminate Potential | 2026-02-24 | PHASE4 |
| NCT05633810 | Montreal Heart Institute | Diabete Type 2|Cardiovascular Diseases | 2022-12-21 | PHASE3 |
| NCT04377321 | Ministry of Health and Population, Egypt | Treatment Adherence | 2019-10-10 | |
| NCT04264260 | Kaohsiung Medical University Chung-Ho Memorial Hospital|Kaohsiung Medical University | Hepatocellular Carcinoma Stage IIIB|Cholangiocarcinoma, Intrahepatic|Cholangiocarcinoma; With Hepatocellular Carcinoma|Hepatocellular Carcinoma Stage IV | 2019-12-24 | PHASE2 |
| NCT02140372 | NYU Langone Health | Healthy | 2014-05 | PHASE4 |
| NCT05726019 | University of Sao Paulo General Hospital | Coronary Artery Disease|Acute Coronary Syndrome|Coronary Artery Bypass|Myocardial Reperfusion|Postpericardiotomy Syndrome|Postoperative Atrial Fibrilation|Perioperative Myocardial Infarction | 2022-02-05 | PHASE2 |
| NCT00128453 | Azienda Sanitaria Locale 3, Torino | Pericarditis | 2005-08 | PHASE3 |
| NCT00960193 | Mutual Pharmaceutical Company, Inc. | Healthy | 2009-02 | PHASE1 |
| NCT06054100 | Ain Shams University | Acute Coronary Syndrome|STEMI | 2020-02-01 | PHASE3 |
| NCT06578182 | Sint Maartenskliniek|ZonMw: The Netherlands Organisation for Health Research and Development|RSMK|Tiofarma|Dutch Arthritis Foundation Reuma Nederland | Osteoarthritis, Knee|Osteoarthritis, Hip | 2025-01-01 | PHASE3 |
| NCT00983931 | Mutual Pharmaceutical Company, Inc. | Pharmacokinetics|Healthy | 2008-08 | PHASE1 |
| NCT04367168 | Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran | COVID | 2020-05-27 | PHASE2 |
| NCT06342609 | Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center | Coronary Artery Disease | 2023-03-15 | PHASE4 |
| NCT07349875 | Nanjing First Hospital, Nanjing Medical University | Coronary Artery Disease (CAD) | 2026-01-01 | PHASE4 |
| NCT04420624 | University Hospital, Montpellier | Myocardial Infarction, Acute | 2020-12-04 | PHASE2|PHASE3 |
| NCT04324463 | Population Health Research Institute|Bayer | Coronavirus|Severe Acute Respiratory Syndrome | 2020-04-21 | PHASE3 |
| NCT06731595 | St. Vincent Cardiovascular Research Institute|Asenson Sacred Heart - Pensacoloa, FL | Atrial Fibrillation|Catheter Ablation|Pericarditis | 2021-05-20 | PHASE2 |
| NCT04949516 | Wonkwang University Hospital | Acute Coronary Syndrome|Drug-Eluting Stents | 2021-06-15 | PHASE4 |
| NCT01416402 | Gilead Sciences | Hyperuricemia|Gout | 2011-08 | PHASE2 |
| NCT02281305 | G.Gennimatas General Hospital|Academy of Athens | Acute Myocardial Infarction | 2014-10 | PHASE4 |
| NCT02366091 | Johns Hopkins University|National Heart, Lung, and Blood Institute (NHLBI) | Coronary Artery Disease | 2015-01 | PHASE2 |
| NCT04328480 | Estudios Clínicos Latino América|Population Health Research Institute | COVID-19 | 2020-04-17 | PHASE3 |
| NCT04363437 | Maimonides Medical Center | Coronavirus Infection | 2020-04-26 | PHASE2 |
| NCT06352632 | The George Institute|University of Calgary|Berry Consultants | Stroke | 2024-09-26 | PHASE3 |
| NCT06280976 | University of Louisville | Coronary Artery Disease|Atherosclerosis|Heart Attack | 2024-03-01 | PHASE4 |
| NCT02035891 | Chongqing Medical University | Diabetic Nephropathy | 2013-12 | NA |
| NCT06090890 | Fu Wai Hospital, Beijing, China | In-stent Restenosis | 2023-10-30 | PHASE4 |
| NCT03021343 | Jordan Collaborating Cardiology Group | Arrhythmia | 2012-10 | PHASE3 |
| NCT05745818 | Sohag University | Periprocedural Myocardial Infarction|Periprocedural Myocardial Injury | 2023-03-01 | |
| NCT01123395 | Mutual Pharmaceutical Company, Inc. | Healthy | 2010-05 | PHASE1 |
| NCT02252835 | Gilead Sciences | Gout|Hyperuricemia | 2014-08 | PHASE2 |
| NCT02139046 | Takeda | Gout | 2014-04 | PHASE3 |
| NCT05250596 | Azienda USL Toscana Centro | Non ST Segment Elevation Acute Coronary Syndrome | 2022-02-24 | PHASE2 |
| NCT04906720 | St. Vincent Cardiovascular Research Institute | Atrial Fibrillation|Catheter Ablation|Pericarditis | 2021-05-20 | PHASE2 |
| NCT00004748 | National Center for Research Resources (NCRR)|Tufts Medical Center | Liver Cirrhosis, Biliary | 1989-11 | PHASE3 |
| NCT05709509 | RSD dr. Soebandi|Universitas Jember|University of Brawijaya | ST Elevation Myocardial Infarction|Colchicine|Cardiac Remodeling, Ventricular | 2022-06-01 | PHASE4 |
| NCT05618353 | VA Office of Research and Development|NYU Langone Health | Coronary Artery Disease | 2023-08-21 | PHASE4 |
| NCT00235079 | Azienda Sanitaria Locale 3, Torino | Pericarditis|Recurrence | 2005-11 | PHASE4 |
| NCT05418686 | Assistance Publique - H?pitaux de Paris | Mediterranean Fever|Colchicine Resistance | 2022-12-09 | NA |
| NCT02122484 | G.Gennimatas General Hospital|Evangelismos Hospital | Elective Coronary Artery Bypass Graft Surgery | 2013-11 | PHASE4 |
| NCT02060552 | Tongji Hospital | Primary Gout | 2013-01 | PHASE4 |
| NCT06763055 | The George Institute|University of Calgary | Intracerebral Hemorrhage|Spontaneous Intracerebral Hemorrhage|Supratentorial Intracerebral Haemorrhage|Acute Intracerebral Haemorrhage|Acute Stroke | 2025-02-27 | PHASE3 |
| NCT01075906 | Mutual Pharmaceutical Company, Inc. | Familial Mediterranean Fever | 2010-08 | PHASE1 |
| NCT04382443 | Centro de estudios en Cardiologia Intervencionista | Coronary Artery Disease|Restenosis of Coronary Artery Stent|Atherosclerosis|Acute Coronary Syndrome | 2020-03-12 | PHASE4 |
| NCT06440694 | Ottawa Hospital Research Institute | Venous Thromboembolism | 2025-07-07 | PHASE3 |
| NCT05279690 | Icahn School of Medicine at Mount Sinai | Urothelial Cancer|Metastatic Solid Tumor | 2022-02-14 | PHASE1 |
| NCT02162303 | Montreal Heart Institute | Atherosclerotic Vascular Disease | 2014-05 | PHASE2 |
| NCT03913442 | NYU Langone Health | Osteoarthritis|Osteo Arthritis Knee | 2019-05-15 | PHASE4 |
| NCT03575572 | University of Michigan | Single-ventricle|Heart Diseases | 2018-08-29 | PHASE2|PHASE3 |
| NCT07280572 | Janneke van de Wijgert|European Clinical Research Alliance for Infectious Diseases (ECRAID) | Post COVID Condition | 2025-02-17 | PHASE3 |
| NCT07287345 | Ayesha Ather | Colchicine|Inflammation in Cardiac Surgery|Post Operative Atrial Fibrillation|Inflammatory Markers|Colchicine Adverse Reaction | 2026-01-16 | PHASE4 |
| NCT02095522 | Tel-Aviv Sourasky Medical Center|Tel Aviv Medical Center | NSTEMI | 2014-03 | NA |
| NCT05855746 | Assistance Publique - H?pitaux de Paris|Hospices Civils de Lyon|Fonds de Dotation ACTION | Acute Myocarditis | 2024-07-16 | PHASE3 |
| NCT04008316 | Assistance Publique - H?pitaux de Paris | IgA Vasculitis | 2019-11-12 | PHASE3 |
| NCT03874338 | NYU Langone Health|Population Health Research Institute|National Heart, Lung, and Blood Institute (NHLBI) | Neutrophils.Hypersegmented | Bld-Ser-Plas|STEMI - ST Elevation Myocardial Infarction | 2019-03-04 | |
| NCT05737680 | Hippocration General Hospital | Pericarditis Idiopathic Recurrent | 2023-02 | PHASE3 |
| NCT01481233 | Milton S. Hershey Medical Center | Prostate Cancer | 2013-05 | PHASE2 |
| NCT06472908 | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Coronary Heart Disease|Percutaneous Coronary Intervention|Colchicine | 2024-07-09 | PHASE3 |
| NCT04492358 | Maria Joyera Rodríguez | Covid19 | 2020-10-22 | PHASE2|PHASE3 |
| NCT02500641 | Menarini International Operations Luxembourg SA | Gout | 2015-08-17 | PHASE4 |
| NCT06020300 | National University of Malaysia | STEMI | 2023-07-28 | PHASE4 |
| NCT05006001 | En Chu Kong Hospital | Renal Impairment|Gout|Colchicine Adverse Reaction|Nonsteroidals (NSAIDs)Toxicity | 2012-01-01 | |
| NCT05873881 | Hamilton Health Sciences Corporation|Population Health Research Institute|Canadian Institutes of Health Research (CIHR) | Heart Failure | 2024-01-29 | PHASE3 |
| NCT04130204 | Dyve Biosciences, Inc. | Gout | 2020-02-12 | PHASE2 |
| NCT02330796 | Revive Therapeutics, Ltd. | Gout | 2015-04 | PHASE2 |
| NCT04326790 | National and Kapodistrian University of Athens | Corona Virus Disease 19 (Covid 19) | 2020-04-03 | PHASE2 |
| NCT06102720 | Mikhail Zykov | Ischemic Stroke | 2023-01-12 | PHASE4 |
| NCT06798714 | Tomsk Cardiology Research Institute | Coronary Artery Disease|Atrial Fibrillation|Coronary Artery Bypass Grafting|Colchicine | 2025-01-20 | PHASE4 |
| NCT04139655 | University of British Columbia|Providence Health & Services|Vancouver Coastal Health | Myocardial Infarction|Myocardial Injury|Major Adverse Cardiac Events|Infectious Complications | 2020-09-01 | NA |
| NCT01018420 | Mutual Pharmaceutical Company, Inc. | Pharmacokinetics | 2007-11 | PHASE1 |
| NCT01112982 | University of South Florida|Takeda Pharmaceuticals North America, Inc. | Gout | 2010-05 | PHASE4 |
| NCT05168137 | Mahidol University|Thai AIDs society | HIV Infections|Inflammatory Markers|Colchicine Adverse Reaction | 2020-02-01 | PHASE4 |
| NCT02083510 | Scripps Translational Science Institute | Hypertriglyceridemia|Gout|Pericarditis | 2014-02 | EARLY_PHASE1 |
| NCT04160117 | Population Health Research Institute | Atrial Fibrillation|Recurrence | 2020-01-14 | PHASE3 |
| NCT00700297 | Tehran University of Medical Sciences | Behcet´s Syndrome | 2002-08 | PHASE2 |
| NCT03226899 | Ironwood Pharmaceuticals, Inc.|Medpace, Inc. | Gout|Chronic Kidney Disease (CKD) | 2017-07-19 | PHASE4 |
| NCT07247734 | Asger Lund, MD|University of Copenhagen | Type 1 Diabetes|Chronic Inflammation|Insulin Sensitivity | 2025-12-01 | PHASE2 |
| NCT06604611 | Dongying Zhang|National Natural Science Foundation of China | Heart Failure|Heart Failure With Preserved Ejection Fraction (HFPEF)|Chronic Inflammation|Inflammation|Colchicine | 2024-10-31 | PHASE4 |
| NCT06212271 | University of Pennsylvania|Doris Duke Charitable Foundation | Peripheral Artery Disease | 2024-09-25 | EARLY_PHASE1 |
| NCT04875702 | Massachusetts General Hospital|National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | Gout | 2024-02-22 | PHASE4 |
| NCT05038449 | Shanghai Public Health Clinical Center|Kunming Pharmaceuticals, Inc. | Covid19|Colchicine | 2021-09-06 | NA |
| NCT01084278 | Takeda | Pharmacokinetics | 2010-05 | PHASE4 |
| NCT04848857 | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Acute Coronary Syndrome | 2021-05-03 | PHASE4 |
| NCT05677555 | Assaf-Harofeh Medical Center | End Stage Renal Disease on Dialysis | 2022-11-01 | PHASE2 |
| NCT05472337 | Pontificia Universidad Catolica de Chile|Fondo Nacional de Desarrollo Científico y Tecnológico, Chile | Acute Coronary Syndrome | 2022-08-01 | PHASE2 |
| NCT00000577 | Milton S. Hershey Medical Center|National Heart, Lung, and Blood Institute (NHLBI) | Asthma|Lung Diseases | 1993-09 | PHASE3 |
| NCT01173107 | Seoul National University Hospital | Chronic Kidney Disease | 2010-12 | PHASE4 |
| NCT06279000 | Cantonal Hospital of St. Gallen | Cardiovascular Diseases|Cardiovascular Complication|Perioperative Complication|Myocardial Injury|Myocardial Injury After Noncardiac Surgery (MINS) | 2025-04-20 | PHASE3 |
| NCT01985425 | Population Health Research Institute|Canadian Institutes of Health Research (CIHR) | Atrial Fibrillation|Thoracic Surgery | 2014-04 | PHASE3 |
| NCT05648734 | Mansoura University | Post-COVID-19 Syndrome|Lung Fibrosis | 2022-03-10 | |
| NCT02442921 | Sheba Medical Center|D-Cure, Israel | Diabetic Nephropathies | 2016-02-22 | PHASE1|PHASE2 |
| NCT05637398 | I.M. Sechenov First Moscow State Medical University | HFpEF - Heart Failure With Preserved Ejection Fraction|Colchicine | 2022-12-15 | PHASE1|PHASE2 |
| NCT00179413 | Beth Israel Deaconess Medical Center|Schering-Plough | Hepatitis C Virus|Advanced Fibrosis|Cirrhosis | 2000-01-15 | PHASE4 |
| NCT06130059 | University of Texas Southwestern Medical Center | Heart Failure|Inflammation | 2024-04-24 | PHASE2 |
| NCT01021020 | Mutual Pharmaceutical Company, Inc. | Healthy | 2007-09 | PHASE1 |
| NCT03659058 | Zagazig University | Fibrosis, Liver | 2016-03-02 | NA |
| NCT06158698 | Niguarda Hospital|European Union|Ministry of Health, Italy|Mario Negri Institute for Pharmacological Research|University of Milano Bicocca | Cardiomyopathies|Myocarditis|Inflammatory Cardiomyopathy|Heart Failure|Ventricular Arrythmia | 2023-11-14 | PHASE3 |
| NCT00128427 | Azienda Sanitaria Locale 3, Torino | Postpericardiotomy Syndrome | 2005-06 | PHASE3 |
| NCT06813079 | University Health Network, Toronto | Pancreatic Ductal Carcinoma|Advanced Cancer|Epithelial Tumor | 2025-02-17 | PHASE2 |
| NCT07074990 | Tanta University | Sepsis at Intensive Care Unit | 2023-11-01 | NA |
| NCT04303689 | University of Copenhagen|University of Aarhus | Essential Hypertension | 2020-08-01 | NA |
| NCT05956145 | University of Sao Paulo | Platelet Aggregation, Spontaneous|Coronary Artery Disease | 2021-06-17 | NA |
| NCT03905759 | doaa rashwan | Postoperative Atrial Fibrillation | 2019-04-03 | PHASE2|PHASE3 |
| NCT01399008 | Gilead Sciences | Gout | 2011-06 | PHASE2 |
| NCT00983294 | Mutual Pharmaceutical Company, Inc. | Pharmacokinetics | 2008-07 | PHASE1 |
| NCT04697602 | National Taiwan University Hospital|National Taiwan University Hospital, Yun-Lin Branch | Gout | 2021-01-20 | NA |
| NCT06874192 | Virginia Commonwealth University | Statin Adverse Reaction | 2025-03-12 | PHASE1 |
| NCT05734612 | Indonesia University | Reperfusion Injury, Myocardial | 2022-12-04 | PHASE3 |
| NCT04322565 | Azienda Ospedaliero-Universitaria di Parma | Coronavirus Infections|Pneumonia, Viral | 2020-04-20 | PHASE2 |
| NCT04218786 | Shifa Tameer-e-Millat University|Rawalpindi Institute of Cardiology | Myocardium; Injury|Myocardial Infarction|Myocardial Ischemia | 2025-12 | PHASE2 |
| NCT02624180 | Johns Hopkins University|National Heart, Lung, and Blood Institute (NHLBI) | Coronary Artery Disease|Human Immunodeficiency Virus | 2015-11 | PHASE2 |
| NCT06930885 | Hospital do Coracao | Atherothrombotic Diseases|Atherosclerotic Cardiovascular Disease (ASCVD) | 2025-06-12 | PHASE3 |
| NCT00723268 | Mashhad University of Medical Sciences|University of Tehran | Oral Aphthae | 2007-05 | PHASE2 |
| NCT01755949 | Mayo Clinic|Takeda|Detiger Funds | Atrial Fibrillation | 2013-03 | PHASE2 |
| NCT05503225 | Chinese University of Hong Kong | ICAD - Intracranial Atherosclerotic Disease | 2022-11-28 | PHASE2 |
| NCT01005121 | Prof.Avi Livneh | Diabetic Nephropathy | 2009-12 | PHASE2 |
| NCT06855433 | Brigham and Women´s Hospital|Rheumatology Research Foundation | CPPD - Calcium Pyrophosphate Deposition Disease | 2026-04-10 | PHASE2 |
| NCT02175589 | Rambam Health Care Campus|Schneider Children´s Hospital | Familial Mediterranean Fever | 2014-06 | PHASE2 |
| NCT04500665 | Brigham and Women´s Hospital|National Heart, Lung, and Blood Institute (NHLBI) | Chronic Kidney Diseases | 2021-11-01 | PHASE2 |
| NCT02282098 | Population Health Research Institute | Atrial Fibrillation|Stroke | 2014-11 | PHASE3 |
| NCT05890664 | University Hospital, Basel, Switzerland|Swiss Heart Foundation|Fondation Machaon, Switzerland, Genf|Foundation for Cardiovascular Research Basel | Atrial Fibrillation|Cardiac Arrhythmia | 2024-04-14 | PHASE3 |
| NCT05949281 | Asger Lund, MD|University of Copenhagen|Juvenile Diabetes Research Foundation | Type 1 Diabetes|Cardiovascular Diseases|Chronic Inflammation | 2023-08-29 | PHASE2 |
| NCT01709981 | NYU Langone Health|Takeda | Coronary Artery Disease | 2013-05-30 | PHASE4 |
| NCT05151614 | University of Baghdad | COVID-19 Pandemic | 2021-04-01 | PHASE1 |
| NCT01552187 | Maria Vittoria Hospital | Cardiac Surgery|Post-pericardiotomy Syndrome|Atrial Fibrillation|Pericardial Effusion|Pleural Effusion | 2012-03 | PHASE3 |
| NCT05698680 | University Medicine Greifswald|University of G?ttingen|Wuerzburg University Hospital | Acute Gout | 2023-01-18 | PHASE4 |
| NCT06837623 | Cairo University | HFpEF - Heart Failure With Preserved Ejection Fraction | 2024-07-01 | PHASE3 |
| NCT07462325 | Chinese Academy of Medical Sciences, Fuwai Hospital | Coronary Heart Disease (CHD) | 2026-03-01 | PHASE4 |
| NCT05459974 | Stony Brook University | Atrial Fibrillation | 2022-06-20 | PHASE3 |
| NCT05324423 | The Affiliated Hospital of Qingdao University | Gout | 2021-10-18 | PHASE1 |
| NCT01017042 | Mutual Pharmaceutical Company, Inc. | Pharmacokinetics | 2007-09 | PHASE1 |
| NCT00840489 | Hospital Universitario Ramon y Cajal | Chronic Hepatitis C | 2009-01 | PHASE2 |
| NCT02551094 | Montreal Heart Institute | Coronary Artery Disease|Myocardial Infarction | 2015-12-04 | PHASE3 |
| NCT05253794 | Ottawa Heart Institute Research Corporation | Aortic Stenosis|Inflammation | 2022-07-01 | PHASE2|PHASE3 |
| NCT04539873 | Fundación Universitaria de Ciencias de la Salud|Hospital de San Jose | Corona Virus Infection | 2021-04-30 | PHASE3 |
| NCT04527562 | Dhaka Medical College | Covid19 | 2020-07-14 | NA |
| NCT04516941 | Insel Gruppe AG, University Hospital Bern|Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company | SARS-CoV Infection|COVID-19 | 2021-01-21 | PHASE3 |
| NCT05159219 | Population Health Research Institute | Intracranial Hemorrhages | 2022-08-04 | PHASE2 |
| NCT07026994 | Huashan Hospital|Peking Union Medical College Hospital|West China Hospital | Cerebral Amyloid Angiopathy|Intracerebral Hemorrhage Lobar | 2025-06-18 | PHASE2 |
| NCT05739929 | Helwan University | Coronary Artery Disease | 2023-03-01 | PHASE3 |
| NCT01336686 | Gilead Sciences | Hyperuricemia|Gout | 2011-05 | PHASE2 |
| NCT04359095 | Universidad Nacional de Colombia|Pontificia Universidad Javeriana|Clínica Colsanitas-Clínica Universitaria Colombia|Hospital Universitario San Ignacio|Hospital Universitario Nacional de Colombia (HUN)|Fundación Cardioinfantil Instituto de Cardiología|Clínica Infantil Santa María del Lago | COVID-19 | 2020-08-18 | PHASE2|PHASE3 |
| NCT07476625 | Wenjie Zheng|Nanjing Children´s Hospital|Children´s Hospital of Soochow University|The First Affiliated Hospital of Xiamen University|Tianjin Children´s Hospital|Ningbo Women & Children´s Hospital|Jinan children´s hospital|Jiangxi Province Children´s Hospital | Periodic Fever, Aphthous Stomatitis, Pharyngitis, and Adenitis Syndrome | 2026-04-01 | NA |
| NCT03156816 | Hospices Civils de Lyon | Myocardial Infarction | 2018-07-23 | PHASE2 |
| NCT04355585 | Brigham and Women´s Hospital|Harvard Medical School (HMS and HSDM) | Colchicine Mechanism of Action | 2020-05-06 | PHASE1 |
| NCT02926248 | Hospital for Special Surgery, New York | Manipulation Under Anesthesia | 2016-05 | PHASE4 |
| NCT03888846 | Ipekyolu Ilac Ltd. Sti|Istanbul University - Cerrahpasa | Beh?et Disease Affecting Oral Mucosa | 2019-03-25 | PHASE2 |
| NCT04654416 | Clínica Medellín - Grupo Quirónsalud | Covid-19 | 2020-03-20 | |
| NCT07143136 | Assiut University | Non ST-Segment Elevation Myocardial Infarction | 2025-08-10 | EARLY_PHASE1 |
| NCT04056039 | Hospital Central "Dr. Ignacio Morones Prieto" | Cardiovascular Diseases|Arthritis, Rheumatoid | 2018-08-14 | PHASE2 |
| NCT04375202 | University Of Perugia | COVID-19 | 2020-04-18 | PHASE2 |
| NCT05347316 | University of Sao Paulo General Hospital | Atherosclerosis|Inflammatory Response|Coronary Disease | 2022-03-07 | PHASE1 |
| NCT04381936 | University of Oxford|UK Research and Innovation|National Institute for Health Research, United Kingdom|Wellcome Trust|Bill and Melinda Gates Foundation|Department for International Development, United Kingdom|Health Data Research UK|Medical Research Council Population Health Research Unit|NIHR Health Protection Research Unit in Emerging and Zoonotic Infections|Flu Lab | Pneumonia | 2020-03-19 | PHASE3 |
| NCT00984009 | Mutual Pharmaceutical Company, Inc. | Pharmacokinetics | 2008-09 | PHASE1 |